BREAKTHROUGH T1D
Accelerating Clinical Trials Evaluating Disease-Modifying Therapies For T1D
Accelerating Clinical Trials Evaluating Disease-Modifying Therapies For T1D is a funding opportunity from BREAKTHROUGH T1D, up to $64.5M. Its application deadline is not stated in the source record.
We could not verify this deadline.
This listing carries no application deadline we can confirm, so it may no longer be open. Check the official solicitation before investing time, and create a free account to see opportunities we can verify are live.
Overview
Accelerating Clinical Trials Evaluating Disease-Modifying Therapies For T1D Letters of intent (LOI’s) are sought from academic and/or industry applicants for clinical trials to evaluate drugs and biologics to delay, halt, or reverse T1D through supporting or expanding endogenous beta cell survival and function,…